Natasha A. Hernday's Insider Trades & SAST Disclosures
Natasha A. Hernday's most recent trade in Janux Therapeutics Inc was a trade of 16,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Natasha A. Hernday.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 8,350 | 8,350 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 4,111 | 4,111 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 2,500 | 7,500 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 1,231 | 6,231 | - | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 15,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 4,881 | 4,881 | - | - | Non-Qualified Share Option (right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 3,035 | 3,035 (0%) | 0% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | A. Hernday Natasha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,650 | 7,650 | - | - | Stock Option (Right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 15 Dec 2020 | 4,000 | 4,000 | - | 25 | 100,000 | 8.625% Series A Cumulative Perpetual Preferred Stock |
| Alpine Immune Sciences Inc | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| XOMA Corp | Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 13,251 | 13,251 | - | - | Non-Qualified Share Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges